Your browser doesn't support javascript.
loading
Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers.
Su, Cheng; Lv, Yufang; Lu, Wenhao; Yu, Zhenyuan; Ye, Yu; Guo, Bingqian; Liu, Deyun; Yan, Haibiao; Li, Tianyu; Zhang, Qingyun; Cheng, Jiwen; Mo, Zengnan.
Afiliação
  • Su C; Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Lv Y; Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Lu W; Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Yu Z; Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Ye Y; Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Guo B; Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Liu D; Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Yan H; Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Li T; Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Zhang Q; Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Cheng J; Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Mo Z; Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
Front Oncol ; 11: 719564, 2021.
Article em En | MEDLINE | ID: mdl-34722263

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article